34
https://pubmed.ncbi.nlm.nih.gov/38115613
The abstract suggests a potential rise in autoimmune diseases following the COVID-19 pandemic, due to molecular mimicry between SARS-CoV-2 and human proteins, and the impact of inflammation caused by the virus.